CRIS Current Research Information System

BELLUZZI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.933
EU - Europa 2.707
AS - Asia 929
AF - Africa 133
SA - Sud America 17
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.735
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.909
IT - Italia 1.038
SE - Svezia 445
GB - Regno Unito 366
SG - Singapore 318
CN - Cina 291
DE - Germania 218
RU - Federazione Russa 142
IE - Irlanda 124
VN - Vietnam 114
IN - India 105
FR - Francia 67
UA - Ucraina 61
CH - Svizzera 52
TG - Togo 48
BG - Bulgaria 47
CI - Costa d'Avorio 44
JO - Giordania 43
EE - Estonia 26
ZA - Sudafrica 25
CA - Canada 19
NL - Olanda 19
BE - Belgio 18
FI - Finlandia 18
AT - Austria 15
AU - Australia 13
IR - Iran 13
BR - Brasile 12
ES - Italia 10
GR - Grecia 10
RO - Romania 7
ID - Indonesia 6
NG - Nigeria 6
PH - Filippine 6
SA - Arabia Saudita 6
HK - Hong Kong 5
HR - Croazia 5
CL - Cile 4
MU - Mauritius 4
TR - Turchia 4
UZ - Uzbekistan 4
BA - Bosnia-Erzegovina 3
BZ - Belize 3
HU - Ungheria 3
LB - Libano 3
LT - Lituania 3
MY - Malesia 3
AE - Emirati Arabi Uniti 2
DK - Danimarca 2
EU - Europa 2
HN - Honduras 2
LY - Libia 2
MA - Marocco 2
PK - Pakistan 2
PT - Portogallo 2
SM - San Marino 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
EG - Egitto 1
ET - Etiopia 1
IL - Israele 1
KR - Corea 1
LK - Sri Lanka 1
NO - Norvegia 1
PE - Perù 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 6.735
Salva come PNG Salva come JPEG
Città #
Chandler 408
Southend 313
Singapore 282
Fairfield 246
Houston 234
Ashburn 223
Santa Clara 173
Princeton 123
Bologna 122
Seattle 121
Dublin 118
Ann Arbor 105
Woodbridge 102
Cambridge 86
Boardman 85
Wilmington 85
Rome 55
Berlin 50
Dong Ket 49
Milan 49
Lomé 48
Abidjan 44
Sofia 43
Amman 42
Bern 34
Turin 31
Westminster 30
Nanjing 27
Padova 26
Beijing 25
New York 23
San Diego 21
Jinan 19
Helsinki 16
Yubileyny 15
Guangzhou 14
Hebei 14
Los Angeles 14
Toronto 14
Florence 13
Jiaxing 13
Redmond 13
Shenyang 13
Napoli 12
Pune 12
Saint Petersburg 12
Des Moines 11
Velletri 11
Brussels 10
Dearborn 10
Modena 10
Phoenix 10
Redwood City 10
Vienna 10
Bremen 9
Buffalo 9
Changsha 9
Chicago 9
Naples 9
Olalla 9
Bari 8
Columbus 8
Falls Church 8
Washington 8
Wuhan 8
Frankfurt am Main 7
Haikou 7
San Francisco 7
Tianjin 7
Capaccio 6
Ferrara 6
Genoa 6
Hyderabad 6
Jacksonville 6
Kunming 6
Norwalk 6
Parma 6
Perugia 6
Rimini 6
Sydney 6
Tehran 6
Zhengzhou 6
Boydton 5
Cesenatico 5
Falkenstein 5
Fuzhou 5
Lugano 5
Medford 5
Nuremberg 5
Paris 5
Pesaro 5
Shanghai 5
Anagni 4
Andover 4
Benevento 4
Caserta 4
Castel Maggiore 4
Catania 4
Chengdu 4
Henderson 4
Totale 3.981
Salva come PNG Salva come JPEG
Nome #
Polifenoli ed efficacia antinfiammatoria: lo strano caso del melograno e le malattie croniche intestinali 687
Risposta immunitaria verso Mycobacterium avium paratubercolosis (MAP) in pazienti affetti da Morbo di Crohn 295
Pomegranate: from the Promised Land to calm the fire in Inflammatory Bowel Disease 241
COVID-19 in IBD: The experience of a single tertiary IBD center 212
Inflammation increases NOTCH1 activity via MMP9 and is counteracted by Eicosapentaenoic Acid-free fatty acid in colon cancer cells 186
Clinical application of faecal calprotectin in ulcerative colitis patients 180
Short-term treatment with eicosapentaenoic acid improves inflammation and affects colonic differentiation markers and microbiota in patients with ulcerative colitis 178
Isolation of stem cell populations with trophic and immunoregulatory functions from human intestinal tissues: potential for cell therapy in inflammatory bowel disease. 176
Can POSSUM accurately predict post-operative complications risk in patients with abdominal Crohn’s disease? 175
Pomegranate juice to reduce fecal calprotectin levels in inflammatory bowel disease patients with a high risk of clinical relapse: Study protocol for a randomized controlled trial 167
Intestinal epithelial cells in inflammatory bowel diseases 162
A Mediterranean Diet Mix Has Chemopreventive Effects in a Murine Model of Colorectal Cancer Modulating Apoptosis and the Gut Microbiota 161
IL23R, NOD2/CARD15, ATG16L1 and PHOX2B polymorphisms in a group of patients with Crohn's disease and correlation with sub-phenotypes. 159
Highly Purified Eicosapentaenoic Acid as Free Fatty Acids Strongly Suppresses Polyps in ApcMin/+ Mice 155
Eicosapentaenoic Acid Reduces Fecal Levels of Calprotectin and Prevents Relapse in Patients With Ulcerative Colitis 153
Retention Rate, Persistence and Safety of Adalimumab in Inflammatory Bowel Disease: A Real-Life, 9-Year, Single-Center Experience in Italy 153
New Insight and Knowledge on anti-inflammatory Effectiveness of dietary phenolics: a work-in-progress report of the NIKE Project 147
Mycobacterium avium subspecies paratuberculosis in the etiology of Crohn’s disease, cause or epiphenomenon? 144
null 139
Inflammatory bowel disease: Moving toward a stem cell-based therapy 137
Eicosapentaenoic acid free fatty acid prevents and suppresses colonic neoplasia in colitis-associated colorectal cancer acting on Notch signaling and gut microbiota 134
Pilot study: the use of sulfasalazine for the treatment of acute pouchitis. 134
Sulfasalazine in Prevention of Pouchitis After Proctocolectomy with Ileal Pouch–Anal Anastomosis for Ulcerative Colitis 132
Attachment and mentalizing abilities in patients with inflammatory bowel disease 132
New proteomic approaches for biomarker discovery in inflammatory bowel disease 122
New Insight and Knowledge on anti-inflammatory Effectiveness of dietary phenolics: the NIKE Project 115
Aortic thrombosis recurrence in a Crohn's disease patient 109
5-Aminosalicylic acid in patients with ulcerative colitis in remission: plasma levels after administration of a new rectal enema 106
A proposed staging system and stage-specific interventions for familial adenomatous polyposis 105
Eicosapentaenoic free fatty acid to treat patients with SARS-Cov2 infection 96
null 95
5-Aminosalicylic acid suppositories in the management of ulcerative colitis 94
PROBABILISTIC ASSESSMENT OF SYMPTOMLESS INFLAMMATION IN CROHN’S DISEASE PATIENTS 88
The Effect of Supplementing a Novel n-3 Polyunsaturated Fatty Acids Formulation Containing Schisandra chinensis Extract and Vitamin D3 to a Group of Elite Sport Athletes on Competition Related Stress, Anxiety and Self-confidence 81
5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis? 69
[Abdominal scintigraphy with leukocytes marked with indium-111 in Crohn disease: clinical importance and prognostic usefulness] 67
Analysis of biological variables in Crohn's disease [4] 64
Baseline Histological Findings Do Not Predict the Risk of Subsequent Extension in Patients with Limited Ulcerative Colitis 63
Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion 62
Bioavailability of single and multiple doses of a new oral formulation of 5‐ASA in patients with inflammatory bowel disease and healthy volunteers 60
Efficacy of 5-aminosalicylic acid enemas versus hydrocortisone enemas in ulcerative colitis 54
Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients 52
Influence of steroid treatment's duration in patients with active Crohn's disease 52
Respiratory burst of circulating polymorphonuclear leukocytes and plasma elastase levels in patients with inflammatory bowel disease in remission 49
Macrophage subpopulations in pouchitis 49
Bronchopulmonary involvement in ulcerative colitis 49
Scavenger effect of sulphasalazine (SASP), 5-aminosalicylic acid (5-ASA), and olsalazine (OAZ) (I) 47
Role of rectal formulations: Enemas 46
Scavenger effect of sulfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation 45
Interleukin 1 beta (IL-1 beta) release from fresh and cultured colonic mucosa in patients with ulcerative colitis (UC) 44
A combination of eicosapentaenoic acid-free fatty acid, epigallocatechin-3-gallate and proanthocyanidins has a strong effect on mTOR signaling in colorectal cancer cells. 43
Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease 43
Optimum dosage of 5-Aminosalicylic acid as rectal enemas in patients with active ulcerative colitis 43
Requirements for the use of intestinal action antibiotics in the treatment of ulcerative colitis 43
Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori-positive dyspeptic patients 42
Interleukin 1 in ulcerative colitis 42
Topical treatment with 5-aminosalicylic in distal ulcerative colitis by using a new suppository preparation - A double-blind placebo controlled trial 42
Short report: zinc sulphate supplementation corrects abnormal erythrocyte membrane long‐chain fatty acid composition in patients with Crohn's disease 37
Steroid treatment in active Crohn's disease: a comparison between two regimens of different duration 36
p-ANCA and development of pouchitis in ulcerative colitis patients after proctocolectomy and ileoanal pouch anastomosis 35
Pentasa in maintenance treatment of ulcerative colitis 34
Mucosal concentrations of interleukin-1β, interleukin-6, interleukin-8, and tumor necrosis factor-α in pelvic ileal pouches 32
Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis 31
MRI patterns in a case of 6-thioguanine-related hepatic sinusoidal obstruction syndrome 29
Totale 6.954
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.215
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.215
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020426 0 0 0 0 0 0 0 128 123 78 51 46
2020/2021858 109 68 74 38 32 57 37 34 93 48 69 199
2021/20221.230 42 42 58 95 83 47 41 51 129 106 349 187
2022/20231.608 146 248 121 176 95 125 70 106 280 43 103 95
2023/2024584 43 70 64 56 58 107 37 32 29 48 19 21
2024/20251.163 111 210 142 112 295 98 173 22 0 0 0 0
Totale 6.954